Rel-tert-butyl (5aR,8aR)-3-iodo-5a,6,8,8a-tetrahydro-4H,7H-pyrrolo[3,4-b][1,2,3]triazolo[1,5-d][1,4]oxazine-7-carboxylate

Catalog No. :
ACVTXE245
CAS No. :
2641076-06-2
Molecular Formula :
C12H17IN4O3
Molecular Weight :
392.20

IUPAC Name:tert-butyl (5aR,8aR)-3-iodo-5a,6,8,8a-tetrahydro-4H,7H-pyrrolo[3,4-b][1,2,3]triazolo[1,5-d][1,4]oxazine-7-carboxylate

Rel-tert-butyl (5aR,8aR)-3-iodo-5a,6,8,8a-tetrahydro-4H,7H-pyrrolo[3,4-b][1,2,3]triazolo[1,5-d][1,4]oxazine-7-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameRel-tert-butyl (5aR,8aR)-3-iodo-5a,6,8,8a-tetrahydro-4H,7H-pyrrolo[3,4-b][1,2,3]triazolo[1,5-d][1,4]oxazine-7-carboxylate
IUPAC Nametert-butyl (5aR,8aR)-3-iodo-5a,6,8,8a-tetrahydro-4H,7H-pyrrolo[3,4-b][1,2,3]triazolo[1,5-d][1,4]oxazine-7-carboxylate
Molecular FormulaC12H17IN4O3
Molecular Weight392.20
SMILESO=C(N1C[C@@]2([H])OCC3=C(I)N=NN3[C@]2([H])C1)OC(C)(C)C
InChI KeyFEEGOWJNVSUPHD-VXNVDRBHSA-N
Synonym4H,7H-Pyrrolo[3,4-b][1,2,3]triazolo[1,5-d][1,4]oxazine-7-carboxylic acid, 5a,6,8,8a-tetrahydro-3-iodo-, 1,1-dimethylethyl ester, (5aR,8aR)-rel-;rel-(5aR,8aR)-tert-Butyl 3-iodo-5a,6,8,8a-tetrahydropyrrolo[3,4-b][1,2,3]triazolo[1,5-d][1,4]oxazine-7(4H)-carboxylate
CAS No.2641076-06-2

Synthetic Route by SureRoute

1. ACVTXE245 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVTXE245 route product structure diagram
    ACVTXE2452641076-06-2
Inquiry

2. ACVTXE245 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVTXE245 route product structure diagram
    ACVTXE2452641076-06-2
Inquiry

Comments (0)